KR20110057049A - 기능성 전립선염 치료제 - Google Patents
기능성 전립선염 치료제 Download PDFInfo
- Publication number
- KR20110057049A KR20110057049A KR1020090114259A KR20090114259A KR20110057049A KR 20110057049 A KR20110057049 A KR 20110057049A KR 1020090114259 A KR1020090114259 A KR 1020090114259A KR 20090114259 A KR20090114259 A KR 20090114259A KR 20110057049 A KR20110057049 A KR 20110057049A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- prostatitis
- functional
- kidney
- urethra
- Prior art date
Links
- 201000007094 prostatitis Diseases 0.000 title abstract description 8
- 239000003814 drug Substances 0.000 title abstract 3
- 239000000284 extract Substances 0.000 claims abstract description 23
- 235000014066 European mistletoe Nutrition 0.000 claims abstract description 4
- 244000152640 Rhipsalis cassutha Species 0.000 claims abstract description 4
- 235000012300 Rhipsalis cassutha Nutrition 0.000 claims abstract description 4
- 235000012907 honey Nutrition 0.000 claims abstract description 3
- 244000273928 Zingiber officinale Species 0.000 claims description 2
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 2
- 229940029991 coriander extract Drugs 0.000 claims description 2
- 235000008397 ginger Nutrition 0.000 claims description 2
- 229940069445 licorice extract Drugs 0.000 claims description 2
- 235000013527 bean curd Nutrition 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 abstract description 11
- 210000003708 urethra Anatomy 0.000 abstract description 7
- 210000003932 urinary bladder Anatomy 0.000 abstract description 6
- 238000001784 detoxification Methods 0.000 abstract description 4
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract description 2
- 244000018436 Coriandrum sativum Species 0.000 abstract description 2
- 235000002787 Coriandrum sativum Nutrition 0.000 abstract description 2
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- 241001105098 Angelica keiskei Species 0.000 abstract 1
- 241000202807 Glycyrrhiza Species 0.000 abstract 1
- 244000162475 Juniperus rigida Species 0.000 abstract 1
- 235000009069 Juniperus rigida Nutrition 0.000 abstract 1
- 241001453758 Lepisorus thunbergianus Species 0.000 abstract 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract 1
- 201000004240 prostatic hypertrophy Diseases 0.000 abstract 1
- 235000015961 tonic Nutrition 0.000 description 7
- 230000001256 tonic effect Effects 0.000 description 7
- 210000002307 prostate Anatomy 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 229910001385 heavy metal Inorganic materials 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000004575 stone Substances 0.000 description 4
- 235000021419 vinegar Nutrition 0.000 description 4
- 239000000052 vinegar Substances 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 201000008383 nephritis Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010012289 Dementia Diseases 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 241000721662 Juniperus Species 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000022555 Genital disease Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010051482 Prostatomegaly Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000028484 Urethral disease Diseases 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
본 발명은 전립선염 치료에 관한 것으로 더욱 상세하게는 전립선염은 호르몬의 불균형, 중금속 축적, 바이러스감염, 서구적인 식생활과 연관이 있으며 , 전립선 비대증은 아미노산, 비타민류부족, 베타카로틴 또는 아연부족의 요인이 지배적이다. 이를 개선하고자 정혈, 중금속배출, 항염, 호르몬의 균형으로 전립선을 치료하며, 유기 게르마늄, 사포닌, 베타카로틴, 풍부한 비타민류와 미네랄을 공급하여 말초혈관의 확장으로 인한 혈액순환의 소통으로 배뇨를 촉진시키며, 전립선 비대증과 요금실, 신장, 방광, 요도염의 치료와 결석을 제거한다. 또한 간장, 신장을 보하고 면역력을 강화하여 정력을 위한 자양 강장, 강정의 효과를 겸한 기능성 제품을 생산 하고 자 함.
구 성분은 중량별로 볼 때 일엽초 추출물 10-20％, 고수풀추출물 3-8％, 겨우살이추출물 8-12％, 음양곽 추출물 5-10％, 두충 추출물 8-12％, 두송실 추출물 1-3％, 신선초 추출물 12-18％, 감초추출물 3-5％, 생강 추출물 3-8％, 꿀 8-10％로 이루워진 조성물이다.
일엽초, 고수풀, 겨우살이, 음양곽 , 두충, 두송실(노간주나무 열매)
Description
기능성 전립선염 치료에 관한 것으로 더욱 상세 하게는 중금속배출, 해독, 정혈, 항염과 방광, 신장의 결석을 제거하여 요도, 신장, 방광염을 치료하며, 사포닌, 유기 게르마늄, 베타카로틴, 비타민B12외 10여종 의 비타민류, 13종의 미네랄을 체내에 공급하여, 말초혈관을 넓혀 혈액순환의 소통이 원활하게하고 면역력을 강화하여 전립선 비대증을 치료하며, 신장, 간장을 보하고 정력을 충전시키는 자양 강장, 강정제를 제조 하고자함.
현 전립선 치료제는 전립선염, 전립선 비대에 대한 효과가 미흡하다.
본 발명의 전립선 치료제는 전립선염, 비대증 치료 뿐 아니라 관련 장기인 신장, 방광, 요도의 치료를 겸하고, 정혈, 중금속배출, 해독, 항염의 효과와 결석 제거로 신장, 방광, 요도염을 병행 치료한다. 또한 신장, 간장을 보하고 면역력을 강화 시키는 자양 강장, 강정제이다.
호르몬 균형 유지, 중금속 배출, 정혈, 사균, 항염 작용으로 전립선 염증을 제거하며, 전립선 비대증에 효과 있는 베타 카로틴, 유기 게르마늄, 사포닌, 아연, 비타민류, 미네랄을 공급하여 비뇨의 통증 예방과 말초혈관을 넓혀 혈액순환을 원활하게 하여 정상의 배뇨을 유지하며, 결석 제거와 면역력을 강화하여 방광, 요도, 신장염을 치료한다. 또한 신장, 간장을 보하며, 정력에 좋은 자양 강장, 강정제를 겸한 다기능 전립선염 치료제이다.
① 일엽초, 고수풀, 겨우살이의 추출물을 이용하여 신장을 보하고, 중금속 배출, 항균, 결석 제거와 면역력 강화로 요금실 , 빈뇨, 요도, 신장염을 치료 한다 .
또한 치매 예방에 효과가 있다.
② 음양곽, 두충의 추출물은 플라보노이드 배당체가 함유 되여 신장, 간장을 보하며, 말초혈관을 넓혀 혈액순환의 소통으로 전립선 비대의 요인을 치료하며, 정력을 위한 강장, 강정제로 성욕감퇴, 조루를 예방한다.
③ 노간주나무 열매인 두송실은 풍습을 없애고 소변, 요도 생식기 질환을 치료하여 소변을 원활하게 하는 기능과 통풍에 효과가 있다.
④ 신선초는 유기 게르마늄, 사포닌, 각종 미네랄, 풍부한 비타민류, 베타 카로틴을 함유하고 있어 전립선 비대완화와 면역력을 강화하며, 신장 기능을 활성화 하는 자양 강장, 강정의 효능이 있다.
중금속배출, 정혈, 해독, 항암작용과 풍부한 비타민류, 미네랄의 공급으로 전립선, 방광, 요도, 신장염을 치료하고, 결석을 제거하며, 신장, 간장을 보하며, 성욕을 증진시키는 자양 강장, 강정제이다. 또한 치매예방과 통풍, 골다공증을 예방하는 다기능을 갖춘 전립선염 치료제이다.
구 성분의 재료는 세척, 분쇄작업을 하여, 각각 10-20 배가의 물을 넣어 약한 불로 24-48시간 가열하여 물의 량이 절반이 되었을때 여과 후 고압 추출하여 사용하며, 신선초는 열에 약한 비타민을 함유하고 있어 15-60 ℃에서 가열하여 물의 량이 절반이 될 때 진공감압 농축으로 추출한다. 그리고 두충 잎은 얇게 썰어서 술에 촉촉이 적시어 섬유질이 없어 질때까지 볶은 다음에 상기 위의 방법으로 추출한다. 각 추출 되어진 재료는 정량계량하여 50℃ 이하에서 혼합하여 제품화 한다.
구 성분은 중량별로 볼때
일엽초 추출물 10-20％, 고수풀 추출물 3-8％, 겨우살이추출물 8-12％, 음양곽 잎, 뿌리 추출물 5-10％, 두충껍질 추출물8-12％, 노간주나무 열매인 두송실 추출물1-3％, 신선초 추출물 12-18％, 감초 추출물 3-5％, 생강 3-8％, 꿀 8-10％로 이루워진 조성물이다
[ 구 성 도 ]
[초고압 처리에 의한 미생물 효소 및 조직감의 변화]
[실험 방법]
① 재료 : 당 제품을 발효 적숙인 PH 4.0에서 발효
② 포장 PET/PE 필름(수분 및 기체 차단성)
③ 초고압처리 상온(20℃)에서 200-686 MPa 에서 5분씩
④ 저장 : 30℃ 인큐베이터에서 저장
[살균효과 실시 예]
Claims (1)
- 중량별로 볼때 일엽초 추출물 10-20％, 고수풀 추출물 3-8％, 겨우살이 추출물 8-12％, 음양곽 추출물 5-10％, 두충 추출물 8-12％, 두송실 추출물 1-3％, 신선초 추출물 12-18％,감초 추출물 3-5％, 생강3-8％,꿀 8-12％로 이루워진 조성물
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020090114259A KR20110057049A (ko) | 2009-11-23 | 2009-11-23 | 기능성 전립선염 치료제 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020090114259A KR20110057049A (ko) | 2009-11-23 | 2009-11-23 | 기능성 전립선염 치료제 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20110057049A true KR20110057049A (ko) | 2011-05-31 |
Family
ID=44365323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020090114259A KR20110057049A (ko) | 2009-11-23 | 2009-11-23 | 기능성 전립선염 치료제 |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20110057049A (ko) |
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552518A (zh) * | 2011-12-31 | 2012-07-11 | 沈阳药科大学 | 四味中药在解除肝肾毒性方面的应用 |
| CN102670826A (zh) * | 2012-05-11 | 2012-09-19 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| CN103070995A (zh) * | 2012-12-30 | 2013-05-01 | 李江 | 一种治疗前列腺炎的中药 |
| CN104013765A (zh) * | 2014-05-20 | 2014-09-03 | 柳晖 | 一种治疗肝肾阴虚的中药组合物 |
| WO2015060673A1 (ko) | 2013-10-23 | 2015-04-30 | 주식회사 카엘젬백스 | 전립선 비대증 치료 및 예방용 조성물 |
| CN104771736A (zh) * | 2015-04-24 | 2015-07-15 | 陈华全 | 治疗前列腺增生的中药前列通 |
| CN104815227A (zh) * | 2015-05-29 | 2015-08-05 | 合肥丰瑞隆生物科技有限公司 | 一种治疗前列腺炎的中药 |
| CN104971308A (zh) * | 2015-06-29 | 2015-10-14 | 贝忠东 | 一种治疗慢性前列腺炎的中药组合物 |
| CN105031424A (zh) * | 2015-09-15 | 2015-11-11 | 徐辉 | 一种治疗前列腺炎的药物 |
| CN105079702A (zh) * | 2015-09-07 | 2015-11-25 | 徐辉 | 一种治疗前列腺炎的药物 |
| US9540419B2 (en) | 2012-05-11 | 2017-01-10 | Gemvax & Kael Co., Ltd. | Anti-inflammatory peptides and composition comprising the same |
| CN107007738A (zh) * | 2017-04-21 | 2017-08-04 | 田生华 | 一种治疗肝肾阴虚的中药组合物及其制剂 |
| US9730984B2 (en) | 2012-05-11 | 2017-08-15 | Gemvax & Kael Co., Ltd. | Composition for preventing or treating rheumatoid arthritis |
| US9907838B2 (en) | 2013-04-19 | 2018-03-06 | Gemvax & Kael Co., Ltd. | Composition and methods for treating ischemic damage |
| US9937240B2 (en) | 2014-04-11 | 2018-04-10 | Gemvax & Kael Co., Ltd. | Peptide having fibrosis inhibitory activity and composition containing same |
| US10034922B2 (en) | 2013-11-22 | 2018-07-31 | Gemvax & Kael Co., Ltd. | Peptide having angiogenesis inhibitory activity and composition containing same |
| CN108992573A (zh) * | 2018-09-04 | 2018-12-14 | 天津太平洋制药有限公司 | 一种补肾通淋药品及其制备工艺 |
| US10383926B2 (en) | 2013-06-07 | 2019-08-20 | Gemvax & Kael Co., Ltd. | Biological markers useful in cancer immunotherapy |
| US10463708B2 (en) | 2014-12-23 | 2019-11-05 | Gemvax & Kael Co., Ltd. | Peptide for treating ocular diseases and composition for treating ocular diseases comprising same |
| US10561703B2 (en) | 2013-06-21 | 2020-02-18 | Gemvax & Kael Co., Ltd. | Method of modulating sex hormone levels using a sex hormone secretion modulator |
| US10662223B2 (en) | 2014-04-30 | 2020-05-26 | Gemvax & Kael Co., Ltd. | Composition for organ, tissue, or cell transplantation, kit, and transplantation method |
| US10835582B2 (en) | 2015-02-27 | 2020-11-17 | Gemvax & Kael Co. Ltd. | Peptide for preventing hearing loss, and composition comprising same |
| US10898540B2 (en) | 2016-04-07 | 2021-01-26 | Gem Vax & KAEL Co., Ltd. | Peptide having effects of increasing telomerase activity and extending telomere, and composition containing same |
| US10967000B2 (en) | 2012-07-11 | 2021-04-06 | Gemvax & Kael Co., Ltd. | Cell-penetrating peptide, conjugate comprising same and composition comprising same |
| US11015179B2 (en) | 2015-07-02 | 2021-05-25 | Gemvax & Kael Co., Ltd. | Peptide having anti-viral effect and composition containing same |
| US11058744B2 (en) | 2013-12-17 | 2021-07-13 | Gemvax & Kael Co., Ltd. | Composition for treating prostate cancer |
| KR20220133702A (ko) * | 2021-03-25 | 2022-10-05 | 수원대학교산학협력단 | 겨우살이 추출물을 유효성분으로 포함하는 전립선 비대증의 예방, 개선 또는 치료용 조성물 |
-
2009
- 2009-11-23 KR KR1020090114259A patent/KR20110057049A/ko not_active Application Discontinuation
Cited By (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552518A (zh) * | 2011-12-31 | 2012-07-11 | 沈阳药科大学 | 四味中药在解除肝肾毒性方面的应用 |
| US9540419B2 (en) | 2012-05-11 | 2017-01-10 | Gemvax & Kael Co., Ltd. | Anti-inflammatory peptides and composition comprising the same |
| US9844584B2 (en) | 2012-05-11 | 2017-12-19 | Gemvax & Kael Co., Ltd. | Composition for preventing or treating sepsis |
| CN102670826A (zh) * | 2012-05-11 | 2012-09-19 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| US9907837B2 (en) | 2012-05-11 | 2018-03-06 | Gemvax & Kael Co., Ltd. | Composition for preventing or treating cachexia |
| US11369665B2 (en) | 2012-05-11 | 2022-06-28 | Gemvax & Kael Co., Ltd. | Anti-inflammatory peptides and composition comprising the same |
| US9730984B2 (en) | 2012-05-11 | 2017-08-15 | Gemvax & Kael Co., Ltd. | Composition for preventing or treating rheumatoid arthritis |
| US10039811B2 (en) | 2012-05-11 | 2018-08-07 | Gemvax & Kael Co., Ltd. | Anti-inflammatory peptides and composition comprising the same |
| US10960056B2 (en) | 2012-05-11 | 2021-03-30 | Gemvax & Kael Co., Ltd. | Anti-inflammatory peptides and composition comprising the same |
| US11857607B2 (en) | 2012-05-11 | 2024-01-02 | Gemvax & Kael Co., Ltd. | Anti-inflammatory peptides and composition comprising the same |
| US10967000B2 (en) | 2012-07-11 | 2021-04-06 | Gemvax & Kael Co., Ltd. | Cell-penetrating peptide, conjugate comprising same and composition comprising same |
| CN103070995A (zh) * | 2012-12-30 | 2013-05-01 | 李江 | 一种治疗前列腺炎的中药 |
| US9907838B2 (en) | 2013-04-19 | 2018-03-06 | Gemvax & Kael Co., Ltd. | Composition and methods for treating ischemic damage |
| US10383926B2 (en) | 2013-06-07 | 2019-08-20 | Gemvax & Kael Co., Ltd. | Biological markers useful in cancer immunotherapy |
| US10561703B2 (en) | 2013-06-21 | 2020-02-18 | Gemvax & Kael Co., Ltd. | Method of modulating sex hormone levels using a sex hormone secretion modulator |
| US9572858B2 (en) | 2013-10-23 | 2017-02-21 | Gemvax & Kael Co., Ltd. | Composition for treating and preventing benign prostatic hyperplasia |
| WO2015060673A1 (ko) | 2013-10-23 | 2015-04-30 | 주식회사 카엘젬백스 | 전립선 비대증 치료 및 예방용 조성물 |
| US10034922B2 (en) | 2013-11-22 | 2018-07-31 | Gemvax & Kael Co., Ltd. | Peptide having angiogenesis inhibitory activity and composition containing same |
| US11058744B2 (en) | 2013-12-17 | 2021-07-13 | Gemvax & Kael Co., Ltd. | Composition for treating prostate cancer |
| US9937240B2 (en) | 2014-04-11 | 2018-04-10 | Gemvax & Kael Co., Ltd. | Peptide having fibrosis inhibitory activity and composition containing same |
| US10662223B2 (en) | 2014-04-30 | 2020-05-26 | Gemvax & Kael Co., Ltd. | Composition for organ, tissue, or cell transplantation, kit, and transplantation method |
| CN104013765A (zh) * | 2014-05-20 | 2014-09-03 | 柳晖 | 一种治疗肝肾阴虚的中药组合物 |
| US10463708B2 (en) | 2014-12-23 | 2019-11-05 | Gemvax & Kael Co., Ltd. | Peptide for treating ocular diseases and composition for treating ocular diseases comprising same |
| US11077163B2 (en) | 2014-12-23 | 2021-08-03 | Gemvax & Kael Co., Ltd. | Peptide for treating ocular diseases and composition for treating ocular diseases comprising same |
| US10835582B2 (en) | 2015-02-27 | 2020-11-17 | Gemvax & Kael Co. Ltd. | Peptide for preventing hearing loss, and composition comprising same |
| CN104771736A (zh) * | 2015-04-24 | 2015-07-15 | 陈华全 | 治疗前列腺增生的中药前列通 |
| CN104815227A (zh) * | 2015-05-29 | 2015-08-05 | 合肥丰瑞隆生物科技有限公司 | 一种治疗前列腺炎的中药 |
| CN104971308A (zh) * | 2015-06-29 | 2015-10-14 | 贝忠东 | 一种治疗慢性前列腺炎的中药组合物 |
| US11015179B2 (en) | 2015-07-02 | 2021-05-25 | Gemvax & Kael Co., Ltd. | Peptide having anti-viral effect and composition containing same |
| CN105079702A (zh) * | 2015-09-07 | 2015-11-25 | 徐辉 | 一种治疗前列腺炎的药物 |
| CN105031424A (zh) * | 2015-09-15 | 2015-11-11 | 徐辉 | 一种治疗前列腺炎的药物 |
| US10898540B2 (en) | 2016-04-07 | 2021-01-26 | Gem Vax & KAEL Co., Ltd. | Peptide having effects of increasing telomerase activity and extending telomere, and composition containing same |
| CN107007738A (zh) * | 2017-04-21 | 2017-08-04 | 田生华 | 一种治疗肝肾阴虚的中药组合物及其制剂 |
| CN108992573A (zh) * | 2018-09-04 | 2018-12-14 | 天津太平洋制药有限公司 | 一种补肾通淋药品及其制备工艺 |
| KR20220133702A (ko) * | 2021-03-25 | 2022-10-05 | 수원대학교산학협력단 | 겨우살이 추출물을 유효성분으로 포함하는 전립선 비대증의 예방, 개선 또는 치료용 조성물 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20110057049A (ko) | 기능성 전립선염 치료제 | |
| CN101283804A (zh) | 保健食品 | |
| CN104740586A (zh) | 一种中药乌发剂及其制备方法 | |
| CN103751317B (zh) | 一种表面活性剂协同微波‑超声波提取枳椇子总黄酮的方法 | |
| CN102113987A (zh) | 含天然植物提取物的化妆品及其制备方法 | |
| KR20170046528A (ko) | 청호, 구절초, 애엽, 인진호, 괴각, 대계, 및 목향을 포함하는 한약 추출물이 함유된 탈모개선 및 탈모방지용 복합조성물 및 그 제조방법 | |
| CN101288635A (zh) | 一种天然黑发祛屑洗发香波 | |
| CN106728056A (zh) | 一种治疗老年人颈肩腰腿痛的外洗液 | |
| CN106852872A (zh) | 一种美白防晒霜的配制方法 | |
| CN107582937B (zh) | 一种脚气水及其制备方法 | |
| CN106389258A (zh) | 一种保湿防晒美白组合物及其制备方法与应用 | |
| CN107034048A (zh) | 一种杀菌止痒祛痘药皂及其制作方法 | |
| CN101757327A (zh) | 防治车轮虫病的中药 | |
| CN106852843A (zh) | 一种抗衰老日霜的配制方法 | |
| CN107811902B (zh) | 一种防脱发育发剂及其制备方法 | |
| CN104288087A (zh) | 一种洁阴湿巾及其制备方法 | |
| CN104414909A (zh) | 一种甲壳胺免洗洗手液 | |
| CN108715560A (zh) | 一种生产肥料用发酵液及其制备方法 | |
| CN104645153A (zh) | 治疗慢性非细菌性前列腺炎的中药组合物 | |
| CN101474378A (zh) | 一种复方女性平衡洗液及其制备方法 | |
| CN106177060A (zh) | 一种美藤果外伤用油 | |
| CN102488640A (zh) | 一种用于抑制粉刺化妆品的植物提取液 | |
| CN106619844A (zh) | 一种修复妊娠纹的药物及其制备方法 | |
| CN104606566A (zh) | 一种治疗肝阳上亢型高血压的中药组合物及其制备方法 | |
| CN104510644A (zh) | 睡莲花精华浴足液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E601 | Decision to refuse application |